Diabetes type 2 CV outcome trials. Time to transition from non-inferiority safety to superiority efficacy trials? Session- Diabetes Outcome Trials. Transitioning to CV efficacy Trials [invited speaker]
Type of Publication
Conference Paper
Year of Publication
2016
Conference Name
Global Cardiovascular Clinical Trialists Forum
Language
Eng
Conference Location
Washington DC, USA
Links to full text